Pluristem to develop stem cell therapy on its own: CEO
Anand Basu, Reuters Pluristem is an Israeli company that is publicly traded on NASDAQ and has been working on a “universal donor” stem cell therapy
March 23, 2011
Anand Basu, Reuters Pluristem is an Israeli company that is publicly traded on NASDAQ and has been working on a “universal donor” stem cell therapy
StemCells Inc Press Release StemCells Inc announced today they are initiating a clinical trial using their fetal derived neural progenitor cells for the treatment of
Washington Examiner February 23, 2011 Hutchinson-Gilfod progeria syndrome is a fast-aging disease that is rare, has no cure, and is fatal. Children with this disease
Cardiology Today PRECISE is The Randomized Clinical Trial of Adipose-Derived Stem Cells in Treatment of Non Revascularizable Ischemic Myocardium, a double blind, placebo-controlled trial involving
By Lucy Johnston Express News Scientists in the UK and Australia have been implementing a new technique to benefit women who have had a mastectomy
Azo Nanotechnology Neural stem cells have recently been shown to possess qualities that make them promising candidates for stem cell replacement therapy and spinal cord
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.